Preventing Risky Drinking in Veterans Treated With Prescription Opioids

Not Applicable

Completed

• Conditions: Alcohol Drinking; Pain; Opiates

• Registration Number: NCT02709317
• Lead Sponsor: University of Pennsylvania

Brief Summary

Veterans who are taking prescription opioids for chronic pain and are engaging in risky drinking are at heightened risk for drug interactions, including overdose and other negative effects, particularly if they are also using benzodiazepines. The investigators propose to test a prevention intervention, designed to reduce rates of risky drinking in veterans receiving prescription opioids to treat their chronic pain. This adaptive, patient-centered intervention provides clinical assessment, brief intervention, monitoring, and extended prevention services delivered through a combination of clinical visits, telephone calls, and text messages. The investigators propose to conduct a study in which veterans (N=300) who are on daily doses of prescription opioids will be randomized to receive 12 months of an adaptive prevention intervention (PI) or to standard care (SC), which consists of a Brief Intervention (BI) with 2 follow-up contacts. Potential participants will be veterans at the Philadelphia VA, and surrounding areas, or the Pittsburgh VA who, based on pharmacy records, are using opioids daily to treat chronic pain. An initial evaluation will identify individuals who also engage in risky alcohol use based on NIAAA-recommended guidelines and meet other inclusion criteria to be enrolled in the study. The evaluation will also identify the use of other medications (e.g., benzodiazepines) that could interact negatively with opioid use. For veterans randomized to the PI condition, a BI is first provided to reduce alcohol to non-hazardous levels and the effects are monitored for one month. Veterans who reduce alcohol use to non-hazardous levels during this one-month period continue in a monitoring track, consisting of tailored text messages and brief monthly telephone contacts. Veterans who continue to drink at risky levels are instead placed in a track that provides tailored text messages and more frequent telephone calls. In addition to monitoring, these calls provide further prevention/BI services to help the veteran reduce alcohol use to non-hazardous levels. Key components of these services are motivational enhancement and development of more effective ways to cope with stress and other triggers for risky alcohol use. All participants will be followed up at 3, 6, 9, 12 and 18 months after baseline. The primary outcome at each follow-up point will be a dichotomous measure of any risky drinking since the prior follow-up (yes/no). Secondary outcomes will include self-reported frequency of heavy drinking, biological measures of alcohol use, other drug use as determined by urine toxicology tests, opioid overdoses, and ratings of depression and pain. Repeated measures analyses will compare the PI and SC conditions on primary and secondary outcomes assessed across an 18-month follow-up. Analyses will also test hypothesized moderation and mediation effects.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-04
• Study First Submitted: 2016-01-28
• Study First Submitted QC: 2016-03-10
• Study First Posted: 2016-03-16
• Primary Completion: 2020-09-30
• Study Completion: 2020-09-30
• Results First Submitted: 2021-10-01
• Status Verified: 2021-12
• Results First Submitted QC: 2021-12-09
• Last Update Submitted: 2021-12-09
• Results First Posted: 2022-03-02
• Last Update Posted: 2022-03-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 108

Inclusion Criteria

• currently be receiving daily treatment with a prescription opioid for chronic pain;
• be 18 years or older;
• have a cell phone capable of receiving text messages;
• and be willing to be in a study where they might receive text messages.

Exclusion Criteria

• meet DSM-V criteria for a moderate to severe alcohol or drug disorder (with the exception of nicotine abuse/dependence);
• have a current psychotic disorder severe enough to require inpatient treatment;
• are participating in substance abuse treatment at the VA or elsewhere (with exception of screening and brief intervention at the VA).

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Rates of Risky Drinking, Week 13	weeks 1 - 13	The primary outcome measure will be rates of the presence of any risky drinking in each week (i.e., more than 4 drinks per drinking day) as reported on the Time Line Follow Back.
Rates of Risky Drinking, Week 26	weeks 14 - 26	Rates of the presence of any risky drinking in each week (14 - 26)
Rates of Risky Drinking, Week 39	weeks 27 - 39	Rates of the presence of any risky drinking in each week (27 - 39)
Rates of Risky Drinking, Week 52	weeks 40 - 52	Rates of the presence of any risky drinking in each week (40 - 52)
Rates of Risky Drinking, Week 78	weeks 53 - 78	Rates of the presence of any risky drinking in each week (53 - 78)

Trial Locations

Locations (3)

Philadelphia VA Medical Center; 🇺🇸 Philadelphia, Pennsylvania, United States

University of Pennsylvania; 🇺🇸 Philadelphia, Pennsylvania, United States

VA Pittsburgh Health System; 🇺🇸 Pittsburgh, Pennsylvania, United States